CABAZITAXEL DR.REDDY'S cabazitaxel 60 mg/1.5 mL concentrated injection vial

Země: Austrálie

Jazyk: angličtina

Zdroj: Department of Health (Therapeutic Goods Administration)

Aktivní složka:

cabazitaxel, Quantity: 60 mg

Dostupné s:

Dr Reddys Laboratories Australia Pty Ltd

Léková forma:

Injection, concentrated

Složení:

Excipient Ingredients: polysorbate 80; citric acid

Podání:

Intravenous Infusion

Jednotky v balení:

1

Druh předpisu:

(S4) Prescription Only Medicine

Terapeutické indikace:

Cabazitaxel Dr.Reddy?s in combination with prednisone or prednisolone is indicated for the treatment of patients with metastatic castration resistant prostate cancer previously treated with a docetaxel containing regimen.

Přehled produktů:

Visual Identification: Clear yellow to brownish-yellow viscous solution.; Container Type: Multiple containers; Container Material: Glass; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Stav Autorizace:

Registered

Datum autorizace:

2018-07-23